Selina Clifford, General Manager Australia and New Zealand at UCB, said, “Our ambition at UCB is to transform the lives of people living with severe and rare diseases such as myasthenia gravis. We are pleased to bring a new treatment option to healthcare professionals and Australians living with generalised myasthenia gravis.” …
Listing delivers access to targeted therapy for Australians living with myasthenia gravis
July 1, 2026 Latest NewsBioPharma
Latest Video
New Stories
-
The minister is following a tried and tested process, but what is the risk in this new world?
July 1, 2026 - - Latest News -
Patient alarm over the potential loss of subsidised access to MS medicines
July 1, 2026 - - Latest News -
Significant day marked by negotiation trigger and wholesaler remuneration changes
July 1, 2026 - - Latest News -
Protection gap leaves older Australians vulnerable this winter
July 1, 2026 - - Latest News -
Pharmacy Guild rejects AMA alarm over broader prescribing powers
July 1, 2026 - - Latest News -
Governments backs inhaled RNA therapy with the potential to change the future of chronic lung disease treatment
July 1, 2026 - -
Major new survey shows patients paying more and waiting longer for medicines
July 1, 2026 - - Latest News